… , particularly for controlling and possibly eliminating P. falciparum malaria. The focus of this
article is to review the current status of malaria vaccines research, with an emphasis of the …

Plasmodium falciparum malaria still remains a major global public health challenge with over
220 million new cases and well over 400,000 deaths annually. Most of the deaths occur in …

… all malaria vaccine candidates that are currently in human clinical testing against Plasmodium
falciparum, as well as selected malaria vaccine … the field of malaria vaccine development. …

… goal for the year 2030 of a malaria vaccine with protective efficacy of at least 75% against
clinical malaria, and development of malaria vaccines that reduce transmission of the parasite (…

… cine against Plasmodium falciparum malaria. Several candidate malaria vaccines are now in
… There is a need for rational approaches to decide how to prioritize different malaria vaccine …

… of vaccines against malaria is complicated by the fact that the protective antigens are specific
for each of the main developmental stages of the parasite, Plasmodium falciparum, in the …

… It is transmitted in nearly 100 countries where approximately 2.0 billion people are exposed
to infection mainly by Plasmodium falciparum and P. vivax. The World Health Organization (…

… Development of a vaccine against Plasmodium falciparum malaria is a key global health …
subunit malaria vaccine, targets the pre-erythrocytic stage of the P. falciparum parasite's …

… falciparum malaria. Plasmodium falciparum malaria causes more than 2 million deaths
annually, 1 and there is currently no effective vaccine to prevent it. The bite of an infected …

… Plasmodium falciparum merozoite surface protein 3 is a malaria vaccine candidate that was
… The vaccine construct was derived from regions fully conserved among various strains and …